Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting

Read more ››
By: GlobeNewswire - 20 May 2024

Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Multiple Functional Endpoints

Read more ››
By: GlobeNewswire - 20 May 2024

ANI Pharmaceuticals Announces the Launch of Kionex® Suspension

Read more ››
By: GlobeNewswire - 20 May 2024

TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing

Read more ››
By: GlobeNewswire - 20 May 2024

At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes

Read more ››
By: GlobeNewswire - 20 May 2024

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

Read more ››
By: GlobeNewswire - 20 May 2024

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

Read more ››
By: GlobeNewswire - 20 May 2024

Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024

Read more ››
By: GlobeNewswire - 20 May 2024

Wugen Announces RMAT and PRIME Designations for WU-CART-007 to Accelerate Regulatory Reviews and Plans to Present Positive Phase 2 Study Findings at European Hematology Association (EHA) 2024 in June

Read more ››
By: GlobeNewswire - 20 May 2024

Reunion Neuroscience Announces Publication of Results from Early Preclinical Studies Demonstrating the Potential of RE104 for Development in Depressive Disorders

Read more ››
By: GlobeNewswire - 20 May 2024

BrightSpring Health Services Announces Onco360® Was Selected as National Pharmacy Partner for OJEMDA™

Read more ››
By: GlobeNewswire - 20 May 2024

Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants

Read more ››
By: GlobeNewswire - 20 May 2024

60 Degrees Pharmaceuticals Funds Babesia spp Testing in Chronic Fatigue Patient Samples in NC State College of Veterinary Medicine Study

Read more ››
By: GlobeNewswire - 20 May 2024

CervoMed to Appoint William Elder as Chief Financial Officer

Read more ››
By: GlobeNewswire - 20 May 2024

Volta Medical presents results from the first transatlantic randomized controlled trial comparing AI-assisted ablation procedure with the conventional treatment for persistent atrial fibrillation patients

Read more ››
By: GlobeNewswire - 20 May 2024

Cerevance to Participate in Precision Neurotherapeutics Panel During the 2024 BIO International Convention

Read more ››
By: GlobeNewswire - 20 May 2024

GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Advanced Solid Tumors

Read more ››
By: GlobeNewswire - 20 May 2024

Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024

Read more ››
By: GlobeNewswire - 20 May 2024

Intercept Presents New Sub-Analyses of Phase 3 POISE Data Showcasing the Effect of OCA on Key Liver Biomarkers and Fibrosis in Patients with PBC at Digestive Disease Week® 2024

Read more ››
By: GlobeNewswire - 20 May 2024

PetMed Express, Inc. Announces Appointment of Justin Mennen to Board of Directors

Read more ››
By: GlobeNewswire - 20 May 2024
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate